177 related articles for article (PubMed ID: 37032449)
21. Risk Factors for Oral Human Papillomavirus Infection Among Young Men Who Have Sex With Men-2 Cities, United States, 2012-2014.
Oliver SE; Gorbach PM; Gratzer B; Steinau M; Collins T; Parrish A; Kerndt PR; Crosby RA; Unger ER; Markowitz LE; Meites E
Sex Transm Dis; 2018 Oct; 45(10):660-665. PubMed ID: 30204745
[TBL] [Abstract][Full Text] [Related]
22. Biomarkers of HPV in head and neck squamous cell carcinoma.
Liang C; Marsit CJ; McClean MD; Nelson HH; Christensen BC; Haddad RI; Clark JR; Wein RO; Grillone GA; Houseman EA; Halec G; Waterboer T; Pawlita M; Krane JF; Kelsey KT
Cancer Res; 2012 Oct; 72(19):5004-13. PubMed ID: 22991304
[TBL] [Abstract][Full Text] [Related]
23. Oral human papillomavirus (HPV) infection in men who have sex with men: prevalence and lack of anogenital concordance.
King EM; Gilson R; Beddows S; Soldan K; Panwar K; Young C; Jit M; Edmunds WJ; Sonnenberg P
Sex Transm Infect; 2015 Jun; 91(4):284-6. PubMed ID: 25887283
[TBL] [Abstract][Full Text] [Related]
24. Control of Epstein-Barr Virus (EBV) in the Oral Cavity Is Associated With Persistence of Oral Human Papillomavirus (HPV)16/18 Among Men From the HPV Infection in Men Study.
Dickey BL; Giuliano AR; Sirak B; Abrahamsen M; Lazcano-Ponce E; Villa LL; Coghill AE
J Infect Dis; 2023 Jan; 227(2):256-260. PubMed ID: 35679351
[TBL] [Abstract][Full Text] [Related]
25. Characterization of human papillomavirus antibodies in individuals with head and neck cancer.
Lang Kuhs KA; Pawlita M; Gibson SP; Schmitt NC; Trivedi S; Argiris A; Kreimer AR; Ferris RL; Waterboer T
Cancer Epidemiol; 2016 Jun; 42():46-52. PubMed ID: 27010729
[TBL] [Abstract][Full Text] [Related]
26. Serum Antibodies to HPV16 Early Proteins Warrant Investigation as Potential Biomarkers for Risk Stratification and Recurrence of HPV-Associated Oropharyngeal Cancer.
Fakhry C; Qualliotine JR; Zhang Z; Agrawal N; Gaykalova DA; Bishop JA; Subramaniam RM; Koch WM; Chung CH; Eisele DW; Califano J; Viscidi RP
Cancer Prev Res (Phila); 2016 Feb; 9(2):135-41. PubMed ID: 26701665
[TBL] [Abstract][Full Text] [Related]
27. Detection of serum biomarkers of HPV-16 driven oropharynx and oral cavity cancer in Brazil.
Sichero L; Gonçalves MG; Bettoni F; Coser EM; Mota G; Nunes RAL; Mercante AMDC; Natalino R; Uno M; Ferreira Alves MJ; Matos LL; Kowalski LP; Kulcsar MAV; de Alvarenga GF; Höfler D; Schroeder L; Waterboer T; Tommasino M; Villa LL
Oral Oncol; 2024 Feb; 149():106676. PubMed ID: 38150987
[TBL] [Abstract][Full Text] [Related]
28. Detection of Circulating HPV16 DNA as a Biomarker for Cervical Cancer by a Bead-Based HPV Genotyping Assay.
Galati L; Combes JD; Le Calvez-Kelm F; McKay-Chopin S; Forey N; Ratel M; McKay J; Waterboer T; Schroeder L; Clifford G; Tommasino M; Gheit T
Microbiol Spectr; 2022 Apr; 10(2):e0148021. PubMed ID: 35225653
[TBL] [Abstract][Full Text] [Related]
29. Oral testing for high-risk human papillomavirus DNA and E6/E7 messenger RNA in healthy individuals at risk for oral infection.
Rollo F; Pichi B; Benevolo M; Giuliani M; Latini A; Lorenzon L; Colafigli M; Frasca M; Pellini R; Cristaudo A; Donà MG
Cancer; 2019 Aug; 125(15):2587-2593. PubMed ID: 31034590
[TBL] [Abstract][Full Text] [Related]
30. Oral human papillomavirus in healthy individuals: a systematic review of the literature.
Kreimer AR; Bhatia RK; Messeguer AL; González P; Herrero R; Giuliano AR
Sex Transm Dis; 2010 Jun; 37(6):386-91. PubMed ID: 20081557
[TBL] [Abstract][Full Text] [Related]
31. HPV16 E6/E7 expression in circulating tumor cells in oropharyngeal squamous cell cancers: A pilot study.
Economopoulou P; Koutsodontis G; Avgeris M; Strati A; Kroupis C; Pateras I; Kirodimos E; Giotakis E; Kotsantis I; Maragoudakis P; Gorgoulis V; Scorilas A; Lianidou E; Psyrri A
PLoS One; 2019; 14(5):e0215984. PubMed ID: 31071126
[TBL] [Abstract][Full Text] [Related]
32. Human papillomavirus and oral cancer: the International Agency for Research on Cancer multicenter study.
Herrero R; Castellsagué X; Pawlita M; Lissowska J; Kee F; Balaram P; Rajkumar T; Sridhar H; Rose B; Pintos J; Fernández L; Idris A; Sánchez MJ; Nieto A; Talamini R; Tavani A; Bosch FX; Reidel U; Snijders PJ; Meijer CJ; Viscidi R; Muñoz N; Franceschi S;
J Natl Cancer Inst; 2003 Dec; 95(23):1772-83. PubMed ID: 14652239
[TBL] [Abstract][Full Text] [Related]
33. Assessing the Potential of HPV16 E6 Seroprevalence as a Biomarker for Anal Dysplasia and Cancer Screening-A Systematic Review and Meta-Analysis.
Tous S; Guillamet M; Waterboer T; Alemany L; Paytubi S
Int J Mol Sci; 2024 Mar; 25(6):. PubMed ID: 38542409
[TBL] [Abstract][Full Text] [Related]
34. HPV Serum Antibodies as Predictors of Survival and Disease Progression in Patients with HPV-Positive Squamous Cell Carcinoma of the Oropharynx.
Dahlstrom KR; Anderson KS; Cheng JN; Chowell D; Li G; Posner M; Sturgis EM
Clin Cancer Res; 2015 Jun; 21(12):2861-9. PubMed ID: 26078432
[TBL] [Abstract][Full Text] [Related]
35. HPV16 antibodies as risk factors for oropharyngeal cancer and their association with tumor HPV and smoking status.
Anderson KS; Dahlstrom KR; Cheng JN; Alam R; Li G; Wei Q; Gross ND; Chowell D; Posner M; Sturgis EM
Oral Oncol; 2015 Jul; 51(7):662-7. PubMed ID: 25957822
[TBL] [Abstract][Full Text] [Related]
36. Oncogenic Oral Human Papillomavirus Clearance Patterns over 10 Years.
D'Souza G; Tewari SR; Troy T; Webster-Cyriaque J; Wiley DJ; Lahiri CD; Palella FJ; Gillison ML; Strickler HD; Struijk L; Waterboer T; Ho K; Kwait J; Lazar J; Weber KM; Fakhry C
Cancer Epidemiol Biomarkers Prev; 2024 Apr; 33(4):516-524. PubMed ID: 38294704
[TBL] [Abstract][Full Text] [Related]
37. Blood-based biomarkers of human papillomavirus-associated cancers: A systematic review and meta-analysis.
Balachandra S; Kusin SB; Lee R; Blackwell JM; Tiro JA; Cowell LG; Chiang CM; Wu SY; Varma S; Rivera EL; Mayo HG; Ding L; Sumer BD; Lea JS; Bagrodia A; Farkas LM; Wang R; Fakhry C; Dahlstrom KR; Sturgis EM; Day AT
Cancer; 2021 Mar; 127(6):850-864. PubMed ID: 33270909
[TBL] [Abstract][Full Text] [Related]
38. Human papillomavirus (HPV) 16 and the prognosis of head and neck cancer in a geographical region with a low prevalence of HPV infection.
López RV; Levi JE; Eluf-Neto J; Koifman RJ; Koifman S; Curado MP; Michaluart-Junior P; Figueiredo DL; Saggioro FP; de Carvalho MB; Kowalski LP; Abrahão M; de Góis-Filho F; Tajara EH; Waterboer T; Boffetta P; Brennan P; Wünsch-Filho V
Cancer Causes Control; 2014 Apr; 25(4):461-71. PubMed ID: 24474236
[TBL] [Abstract][Full Text] [Related]
39. 5-Year Prospective Evaluation of Cytology, Human Papillomavirus Testing, and Biomarkers for Detection of Anal Precancer in Human Immunodeficiency Virus-Positive Men Who Have Sex With Men.
Clarke MA; Cheung LC; Lorey T; Hare B; Landy R; Tokugawa D; Gage JC; Darragh TM; Castle PE; Wentzensen N
Clin Infect Dis; 2019 Aug; 69(4):631-638. PubMed ID: 30418518
[TBL] [Abstract][Full Text] [Related]
40. Performance of oral HPV DNA, oral HPV mRNA and circulating tumor HPV DNA in the detection of HPV-related oropharyngeal cancer and cancer of unknown primary.
Tanaka H; Suzuki M; Takemoto N; Fukusumi T; Eguchi H; Takai E; Kanai H; Tatsumi M; Horie M; Takenaka Y; Yachida S; Inohara H
Int J Cancer; 2022 Jan; 150(1):174-186. PubMed ID: 34486724
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
